Virios Therapeutics, Inc. - VIRI

SEC FilingsOur VIRI Tweets

About Gravity Analytica

Recent News

  • 03.28.2026 - Digestive Disease Week® (DDW) 2021 Presentation – Carol Duffy, PhD; William Pridgen, MD – Active Herpes Simplex Virus Type 1 Infection of the Gastric Mucosa is Associated with Functional Gastrointestinal Disorders: A Pilot Case-Control Study
  • 03.28.2026 - International Association for the Study of Pain (IASP) World Congress 2021 Poster Presentation - William Pridgen, MD; Carol Duffy, PhD; Judy F. Gendreau, MD; R. Michael Gendreau, MD, PhD – The Safety of IMC‑1 in Patients With Fibromyalgia: Phase 2a Study Results
  • 03.28.2026 - EULAR European Congress of Rheumatology 2021 Poster Presentation - William Pridgen, MD; Carol Duffy, PhD; Judy F. Gendreau, MD; R. Michael Gendreau, MD, PhD – IMC‑1, a Fixed Dose Combination of Famciclovir and Celecoxib, Improves Common Symptoms Associated With Fibromyalgia in Addition to Pain: Post Hoc Analysis of a Phase 2a Trial
  • 03.19.2026 - International Association for the Study of Pain (IASP) World Congress 2021 Poster Presentation - William Pridgen, MD; Carol Duffy, PhD; Judy F. Gendreau, MD; R. Michael Gendreau, MD, PhD – The Safety of IMC‑1 in Patients With Fibromyalgia: Phase 2a Study Results
  • 03.19.2026 - Digestive Disease Week® (DDW) 2021 Presentation – Carol Duffy, PhD; William Pridgen, MD – Active Herpes Simplex Virus Type 1 Infection of the Gastric Mucosa is Associated with Functional Gastrointestinal Disorders: A Pilot Case-Control Study
  • 03.19.2026 - EULAR European Congress of Rheumatology 2021 Poster Presentation - William Pridgen, MD; Carol Duffy, PhD; Judy F. Gendreau, MD; R. Michael Gendreau, MD, PhD – IMC‑1, a Fixed Dose Combination of Famciclovir and Celecoxib, Improves Common Symptoms Associated With Fibromyalgia in Addition to Pain: Post Hoc Analysis of a Phase 2a Trial
  • 03.18.2026 - Dogwood Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
  • 03.18.2026 - Dogwood Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
  • 02.17.2026 - Digestive Disease Week® (DDW) 2021 Presentation – Carol Duffy, PhD; William Pridgen, MD – Active Herpes Simplex Virus Type 1 Infection of the Gastric Mucosa is Associated with Functional Gastrointestinal Disorders: A Pilot Case-Control Study
  • 02.17.2026 - International Association for the Study of Pain (IASP) World Congress 2021 Poster Presentation - William Pridgen, MD; Carol Duffy, PhD; Judy F. Gendreau, MD; R. Michael Gendreau, MD, PhD – The Safety of IMC‑1 in Patients With Fibromyalgia: Phase 2a Study Results

Recent Filings

  • 03.26.2026 - EX-99.1 EX-99.1
  • 03.26.2026 - 8-K Current report
  • 03.18.2026 - EX-99.1 EX-99.1
  • 03.18.2026 - 8-K Current report
  • 03.18.2026 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
  • 03.12.2026 - 8-K Current report
  • 03.06.2026 - 4 Statement of changes in beneficial ownership of securities
  • 03.06.2026 - 4 Statement of changes in beneficial ownership of securities
  • 03.06.2026 - 4 Statement of changes in beneficial ownership of securities
  • 03.06.2026 - 4 Statement of changes in beneficial ownership of securities